research
New Approaches to Modulating CSPG Signaling After Spinal Cord Injury
A recent wave of studies is taking a closer look at how chondroitin sulfate proteoglycans (CSPGs) co...
A Glimpse on NVG-291 History
40 Years of Dr. Jerry Silver’s Groundbreaking Research Now Reaches SCI Patients
Dr. Jerry Silver’...
The Impact of Nicotine and Smoking on Spinal Cord Injury Recovery
Nicotine and smoking have long been linked to various negative health outcomes, but their effects on...
Psilocybin and Spinal Cord Injury (SCI)
Overview
Psilocybin is a naturally occurring compound found in certain mushrooms. When taken, the...
Thiorphan: Mechanism, Neuroprotective Effects, and Potential in Spinal Cord Injury and Brain Disorders
Thiorphan is a potent inhibitor of neutral endopeptidase (NEP), also known as CD10, neprilysin, and ...
NVG-291: Exploring Its Potential in Spinal Cord Injury and Neuroprotection
Introduction
NVG-291 is a promising experimental agent designed to address neuroinflammation, a key...
Therapeutic Directions
The biological complexity of spinal cord injury (SCI) makes it unlikely that a single intervention c...
Barriers to Repair – Spinal Cord Injury
Introduction
Repair in the central nervous system is profoundly limited. After spinal cord injury...
Biology of Injury – Spinal Cord Injury
Introduction
Spinal cord injury (SCI) sets off a complex series of biological events that extend ...
BPC-157 – An Emerging Candidate in Spinal Cord Injury Research
BPC-157 (Body Protection Compound-157) is a synthetic peptide composed of 15 amino acids, originally...